Group 1 (PVAC N = 85) | Group 2 (Cryo N = 66) | p value | |
---|---|---|---|
Age (years) | 58 ± 17 [31–72] | 63 ± 12 [29–83] | ns |
Male | 56 (66) | 39 (59) | ns |
CHA2DS2-VASc-score | 2.2 [0–5] | 2.4 [0–5] | ns |
Paroxysmal AF | 58 (68) | 40 (60) | ns |
Left ventricular ejection fraction (%) | 57 ± 8 | 54 ± 7 | ns |
Left atrial diameter (mm) | 43 ± 4 [37–50] | 42 ± 6 [36–53] | ns |
No. of antiarrhythmic drugs | 1.4 ± 1.3 [0–3] | 1.1 ± 1.2 [0–3] | ns |
Amiodarone therapy | 17 (20) | 12 (18) | ns |
No structural heart disease | 44 (52) | 28 (42) | ns |
Hypertension | 42 (49) | 38 (58) | ns |
Coronary artery disease | 22 (26) | 15 (23) | ns |
Chronic obstructive pulmonary disease | 9 (11) | 7 (11) | ns |
Implantable cardiac devicesa | 6 (7) | 7 (11) | ns |